1. McCabe M, Rossi S, Cerza F, Massimino M, Gianno F, Spycher BD, Marcos-Gragera R, Bennett D, Lasalvia P, Didonè F, El Karoui NJ, Ragusa R, Mayer-da-Silva A, Mousavi SM, Trama A; EUROCARE-6 WG. Survival of European adolescents and young adults diagnosed with central nervous system tumours and comparison with younger and older age groups: EUROCARE-6 results. Eur J Cancer. 2025 Sep 9;227:115661.
2. Botta L, Capocaccia R, Bernasconi A, Rossi S, Galceran J, Maso LD, Lepage C, Molinié F, Bouvier AM, Marcos-Gragera R, Vener C, Guevara M, Murray D, Ragusa R, Gatta G, Jooste V, Wg TE. The impact of cancer survivors' extra risk of non-cancer mortality on net survival estimation. Am J Epidemiol. 2025 Aug 19:kwaf148. doi: 10.1093/aje/kwaf148. Epub ahead of print.
3. O'Driscoll J, Tierney PA, McDevitt J, Brennan A, Redaniel MT, Zhang M, Bennett K, Murray D, Mullooly M. Examining the impact of the COVID-19 pandemic on invasive breast cancer incidence in Ireland: A population-based study. Cancer Epidemiol. 2025 Aug;97:102864.
4. Bernasconi A, Toss A, Zattarin E, Mousavi SM, Blum M, Kuehni CE, Katalinic A, Trallero J, Rapiti E, Maso LD, Botta L, Rossi S, Peccatori F, Trama A; EUROCARE-6 Working Group. Prognosis of Breast Cancer in European female adolescents and young adults (AYAs): EUROCARE-6 retrospective cohort results. Breast. 2025 Aug;82:104472.
5. Ssenyonga N, Stiller CA, Marcos-Gragera R, Kuehni CE, Saint-Jacques N, Bulliard JL, Redaniel MT, Nakata K, Schwartz S, De P, Ragusa R, Troussard X, Curado MP, Girardi F, Maynadié M, Valkov M, Guilloteau A, Lima C, Coleman MP, Allemani C; CONCORD Working Group. Conditional survival of children, adolescents and young adults (0-24 years) diagnosed with leukaemia during 2000-2014 world-wide: (CONCORD-3). Eur J Cancer. 2025 Jul 25;225:115445.
6. Trama A, Geerdes EE, Demuru E, De Angelis R, Karim-Kos HE, Troussard X, Bennett D, Marcos-Gragera R, Kuehni CE, Liu H, Bernasconi A, Vener C, Guevara M, Zwaan CM, Mayer-da-Silva A, Paapsi K, Ragusa R, Smith OP; EUROCARE-6 Working Group. Survival of European children, adolescents and young adults diagnosed with haematological malignancies in the period 2000-2013: Results from EUROCARE-6, a population-based study. Eur J Cancer. 2025 Jun 3;222:115336.
7. Botta L, Capocaccia R, Vener C, Bernasconi A, Trama A, Didoné F, Demuru E, De Angelis R, Rossi S, Mousavi SM, Peters F, Bennet D, Mayer-da-Silva A, Jooste V; EUROCARE-6 WG. Estimating cure and risk of death from other causes of adolescent and young adult cancer patients in Europe. Eur J Cancer. 2025 Jun 3;222:115443.
8. Gatta G, Calleja-Agius J, Sandrucci S, Bennet D, Azzopardi MJ, Capocaccia R; EUROCARE WG. Incidence and survival of rare female genital tract cancers in Europe: The EUROCARE-6 study. Eur J Surg Oncol. 2025 Apr;51(4):109996.
9. Zhang M, Tierney P, Brennan A, Murray D, Mullooly M, Bennett K. Modelling the impact of the COVID-19 pandemic on cancer stage migration and excess mortality in Ireland. Prev Med Rep. 2025 Mar 1;52:103020.
10. Trama A, Lasalvia P, Stark D, McCabe MG, van der Graaf W, Gaspar N, Metayer L, Strauss SJ, Ragusa R, Guevara M, Bennett D, Dal Maso L, Batllés AMV, Schindera C, Mousavi SM, Cerza F, Botta L, Ferrari A, Provenzano S; EUROCARE-6 Working Group. Incidence and survival of European adolescents and young adults diagnosed with sarcomas: EUROCARE-6 results. Eur J Cancer. 2025 Feb 25;217:115212.